Deakin University
Browse

File(s) not publicly available

Accuracy and prognostic significance of oncologists' estimates and scenarios for survival time in a randomised Phase 2 trial of regorafenib in advanced gastric cancer

Version 2 2024-06-19, 00:50
Version 1 2021-01-12, 16:57
conference contribution
posted on 2024-06-19, 00:50 authored by A Vasista, A Martin, N Pavlakis, K Sjoquist, S Snow, D Jonker, YJ Chua, R Epstein, A Bonaventura, M Khasraw, SC Varma, N Singhal, DT Ransom, F Aubin, R Burkes, H Lim, F Lemay, S Begbie, MR Stockler, B Kiely
Accuracy and prognostic significance of oncologists' estimates and scenarios for survival time in a randomised Phase 2 trial of regorafenib in advanced gastric cancer

History

Volume

28

Location

Madrid, SPAIN

Start date

2017-09-08

End date

2017-09-12

ISSN

0923-7534

eISSN

1569-8041

Language

English

Author URL

Publication classification

E3 Extract of paper

Title of proceedings

ANNALS OF ONCOLOGY

Event

42nd European-Society-for-Medical-Oncology Congress (ESMO)

Publisher

OXFORD UNIV PRESS

Usage metrics

    Research Publications

    Categories

    Keywords

    Science & TechnologyLife Sciences & BiomedicineOncology111299 Oncology and Carcinogenesis not elsewhere classified3211 Oncology and carcinogenesis

    Licence

    All Rights Reserved

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC